Loading
A phase 2/3 trial in lung cancer, run by Second Affiliated Hospital of Nanchang University, now recruiting.
SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC is a phase 2/3, interventional study registered as NCT07131319 by Second Affiliated Hospital of Nanchang University, with a registry enrolment figure of 30 participants, started 2025-04-21 and due to reach its primary completion in 2028-10-31. Interventions recorded: Spatially Fractionated Radiotherapy (SFRT); Tislelizumab, Carboplatin, Pemetrexed; Tislelizumab, paclitaxel, Carboplatin. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: Surgical resection rate. Lung eligibility wording from the registry: "* The patient has histologically or cytologically confirmed stage III non-small cell lung cancer (NSCLC) that is deemed unresectable after discussion in the multidisciplinary team (MDT), which is classified as T3-4N1-2M0 according to the 8th edition of the American Joint Committee on Cancer (AJCC)". Sites: China. No results are recorded here; the registry entry is the source.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.
Shares Unresectable stage III non-small-cell lung cancer, Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam) and the tag lung-deep-dive.